Suppr超能文献

基于聚合酶链反应的少数等位基因和突变富集方法。

PCR-based methods for the enrichment of minority alleles and mutations.

作者信息

Milbury Coren A, Li Jin, Makrigiorgos G Mike

机构信息

Department of Radiation Oncology, Division of Medical Physics and Biophysics, and Division of DNA Repair and Genome Stability, Dana Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA 02115, USA.

出版信息

Clin Chem. 2009 Apr;55(4):632-40. doi: 10.1373/clinchem.2008.113035. Epub 2009 Feb 6.

Abstract

BACKGROUND

The ability to identify low-level somatic DNA mutations and minority alleles within an excess wild-type sample is becoming essential for characterizing early and posttreatment tumor status in cancer patients. Over the past 2 decades, much research has focused on improving the selectivity of PCR-based technologies for enhancing the detection of minority (mutant) alleles in clinical samples. Routine application in clinical and diagnostic settings requires that these techniques be accurate and cost-effective and require little effort to optimize, perform, and analyze.

CONTENT

Enrichment methods typically segregate by their ability to enrich for, and detect, either known or unknown mutations. Although there are several robust approaches for detecting known mutations within a high background of wild-type DNA, there are few techniques capable of enriching and detecting low-level unknown mutations. One promising development is COLD-PCR (coamplification at lower denaturation temperature), which enables enrichment of PCR amplicons containing unknown mutations at any position, such that they can be subsequently sequenced to identify the exact nucleotide change.

SUMMARY

This review summarizes technologies available for detecting minority DNA mutations, placing an emphasis on newer methods that facilitate the enrichment of unknown low-level DNA variants such that the mutation can subsequently be sequenced. The enrichment of minority alleles is imperative in clinical and diagnostic applications, especially in those related to cancer detection, and continued technology development is warranted.

摘要

背景

在过量野生型样本中识别低水平体细胞DNA突变和少数等位基因的能力,对于表征癌症患者的早期及治疗后肿瘤状态变得至关重要。在过去20年里,许多研究都集中在提高基于PCR的技术的选择性,以增强对临床样本中少数(突变)等位基因的检测。在临床和诊断环境中的常规应用要求这些技术准确、具有成本效益,并且几乎不需要努力进行优化、操作和分析。

内容

富集方法通常根据其富集和检测已知或未知突变的能力进行分类。虽然有几种强大的方法可用于在野生型DNA的高背景下检测已知突变,但能够富集和检测低水平未知突变的技术却很少。一个有前景的进展是COLD-PCR(低温共扩增),它能够富集在任何位置包含未知突变的PCR扩增子,以便随后对其进行测序以确定确切的核苷酸变化。

总结

本综述总结了可用于检测少数DNA突变的技术,重点介绍了有助于富集未知低水平DNA变异体从而随后对突变进行测序的较新方法。在临床和诊断应用中,尤其是与癌症检测相关的应用中,富集少数等位基因至关重要,因此有必要持续进行技术开发。

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验